Steris (BSP:S1TE34) Inventories, Finished Goods : R$2,411 Mil (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Steris Inventories, Finished Goods?

Steris's quarterly finished goods increased from Jun. 2023 (R$2,103 Mil) to Sep. 2023 (R$2,386 Mil) and increased from Sep. 2023 (R$2,386 Mil) to Dec. 2023 (R$2,411 Mil).

Steris's annual finished goods increased from Mar. 2021 (R$995 Mil) to Mar. 2022 (R$1,666 Mil) and increased from Mar. 2022 (R$1,666 Mil) to Mar. 2023 (R$2,106 Mil).

Steris Inventories, Finished Goods Historical Data

The historical data trend for Steris's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Steris Inventories, Finished Goods Chart

Steris Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Inventories, Finished Goods

Get a 7-Day Free Trial

503.33

731.61

995.29

1,666.50

2,105.51

Steris Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Inventories, Finished Goods	Get a 7-Day Free Trial															2,093.09	2,105.51	2,102.55	2,386.33	2,410.73

Steris Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

Steris (BSP:S1TE34) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Steris PLC (BSP:S1TE34) » Definitions » Inventories, Finished Goods

Comparable Companies

Traded in Other Exchanges

STE:USA

Address

5960 Heisley Road, Mentor, OH, USA, 44060

Website

https://www.steris-ir.com

Steris is an Ireland-domiciled medical device company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Additionally, Steris sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its 2015 inversion to Ireland, the firm continues to derive roughly 70% of revenue from its U.S. operations, 10% from the United Kingdom, and the remaining 20% from other international regions.

Steris (BSP:S1TE34) Headlines

No Headlines